Champions Oncology (CSBR) Gross Profit Growth (1y) (2011 - 2026)
Champions Oncology (CSBR) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Champions Oncology |
81.79 Mn |
74.79 Mn |
13.89 Mn |
33.30% |
| Date | Value |
|---|
| Jan 31, 2026 |
33.30% |
| Oct 31, 2025 |
28.25% |
| Jul 31, 2025 |
73.70% |
| Apr 30, 2025 |
-82.52% |
| Jan 31, 2025 |
1.96% |
| Oct 31, 2024 |
22.32% |
| Jul 31, 2024 |
43.31% |
| Apr 30, 2024 |
407.40% |
| Jan 31, 2024 |
-7.17% |
| Oct 31, 2023 |
-27.54% |
| Jul 31, 2023 |
-27.13% |
| Apr 30, 2023 |
195.69% |
| Jan 31, 2023 |
-5.43% |
| Oct 31, 2022 |
-32.60% |
| Jul 31, 2022 |
14.27% |
| Apr 30, 2022 |
-165.89% |
| Jan 31, 2022 |
24.94% |
| Oct 31, 2021 |
126.83% |
| Jul 31, 2021 |
-29.76% |
| Apr 30, 2021 |
-44.78% |
